VivoSim Labs (VIVS) FCF Margin (QoQ) (2011 - 2026)
VivoSim Labs (VIVS) FCF Margin (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.24 Mn |
| Mar 31, 2026 | 327,865.00 |
| Dec 31, 2025 | -27,473.00 |
| Sep 30, 2025 | 196,911.00 |
| Jun 30, 2025 | -655,034.00 |
| Mar 31, 2025 | 351,397.00 |
| Dec 31, 2024 | 134,583.00 |
| Sep 30, 2024 | -120,128.00 |
| Jun 30, 2024 | 156,163.00 |
| Mar 31, 2024 | 6.12 Mn |
| Jun 30, 2023 | -428,467.00 |
| Mar 31, 2023 | -46,170.00 |
| Dec 31, 2022 | 67,880.00 |
| Dec 31, 2019 | 22,347.00 |
| Sep 30, 2019 | 46,937.00 |
| Jun 30, 2019 | -13,568.00 |
| Mar 31, 2019 | -24,214.00 |
| Dec 31, 2018 | -5,095.00 |
| Sep 30, 2018 | 55,946.00 |
| Jun 30, 2018 | -49,907.00 |